搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按相关度排序
按时间排序
HealthDay on MSN
15 小时
Adjuvant Pembrolizumab Improves Survival in Muscle-Invasive Urothelial Cancer
Disease-free survival is significantly longer with adjuvant pembrolizumab than observation among patients with high-risk ...
HealthDay on MSN
1 天
Pembrolizumab + Chemo Beneficial for Early-Stage Triple-Negative Breast Cancer
For patients with early-stage triple-negative breast cancer, neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant ...
Medpage Today on MSN
3 天
Survival Win for Pembrolizumab in Early Triple-Negative Breast Cancer
Notably, patients benefited from pembrolizumab regardless of whether they achieved a pathologic complete response (pCR), ...
Medscape
2 天
Pembrolizumab Approved With Chemotherapy for Malignant Pleural Mesothelioma
Pembrolizumab (Keytruda, Merck) has picked up another indication — this time for the first-line treatment of unresectable ...
Medscape
4 天
Pembrolizumab Plus Chemoradiotherapy Provides Significant Survival Benefit in Cervical Cancer
Patients with locally advanced cervical cancer were randomized to receive either pembrolizumab or placebo in combination with ...
Targeted Oncology
3 天
FDA Approves Frontline Pembrolizumab/Chemotherapy in Advanced Mesothelioma
Pembrolizumab plus chemotherapy is now an approved frontline treatment for patients with unresectable advanced or metastatic ...
oncnursingnews
5 天
Pembrolizumab Plus Chemoradiotherapy May Be New Standard in Locally Advanced Cervical Cancer
Pembrolizumab plus chemoradiotherapy improved survival in patients with previously untreated, high-risk locally advanced ...
oncnursingnews
5 天
Perioperative Pembrolizumab Improves Survival in Early-Stage TNBC
Patients with early-stage triple-negative breast cancer tended to have improved survival with neoadjuvant pembrolizumab plus ...
Targeted Oncology
5 天
Neoadjuvant and Adjuvant Pembrolizumab Extends Survival in Early-Stage TNBC
In KEYNOTE-522, treatment with neoadjuvant pembrolizumab and chemotherapy, followed by adjuvant pembrolizumab, led to ...
MedPage Today
4 天
Survival Win for Pembrolizumab in Early Triple-Negative Breast Cancer
After a median follow-up of 75 months, the 5-year OS was 86.6% in patients who received pembrolizumab (Keytruda) before and after surgery compared with 81.7% in those who received only neoadjuvant ...
12 天
Ivonescimab outperforms pembrolizumab in study for first-line treatment of PD-L1-positive ...
Data from a Phase 3 study has revealed that ivonescimab demonstrates a statistically significant and clinically meaningful ...
emjreviews.com
6 天
Pembrolizumab with Chemoradiotherapy Improves Cervical Cancer Survival: ESMO 2024
Discover the results from the phase 3 ENGOT-cx11/GOG-3047/KEYNOTE-A18 study, presented at ESMO 2024, Barcelona, Spain ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈